FDA Approves Gel to Temporarily Stop Blood Flow
The U.S. Food and Drug Administration has approved LeGoo, a gel that temporarily stops blood flow, according to a news release.
This gel allows surgeons to stop blood flow so they can join blood vessels without the use of clamps or elastic loops.
LeGoo works because it is temperature sensitive, becoming liquid at room temperature and solid at higher temperatures. When injected into a blood vessel, the higher temperature causes the gel to solidify, forming a plug that molds to the blood vessel and stops blood flow for up to 15 minutes. If the plug needs to be removed in less than 15 minutes, a cold pack or cold saline solution can be used.
The gel, manufactured by PluroMed Inc. of Woburn, Mass., is approved for use in blood vessels below the neck that are four millimeters or less in diameter. It is not approved for use in blood vessels supplying blood to the brain.
Related Articles about FDA Approvals:
FDA Approves Wireless Version of Smiths Medfusion Syringe Pump
FDA Clears Siemens' Mobilett Mira Mobile Digital X-Ray System
FDA Clears Calgary Scientific's ResolutionMD to View Images on iPhones, iPads
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
- 5 Areas That Trip Up ASCs During Accreditation Evaluations
- CMS Loosens Medicaid Enrollment Process
- Best Practices: Documentation and Reporting for Post-Operative Pain Management Procedures in Anesthesia
- Joint Commission Appoints Mark Pelletier COO, Division of Accreditation, Certification
- Johns Hopkins: Blood Transfusions Overused During Surgery